nwoodman

I don’t see this as a positive at all. It provides further validity to the market’s view that Fairfax IPO’s are not to be touched with a 10’ pole. Perhaps a bit negative but I just wish they wouldn’t stuff around with these crappy positions.

Minor upgrade to Eurobank from Nida Iqbal at Morgan Stanley on the back of stronger forward guidance. PT €2.01 A strong balance sheet means that Eurobank is one of the the most resilient Greek banks in our coverage. We expect performing loans to grow at a ~5% CAGR in 2023-25. We forecast NIMs to decline ~10bps in 2024 followed by a 18bps contraction in 2025, as we expect the rate-cutting cycle to begin in 2Q24, thus driving asset yields lower. 3Q23 NPE ratio stood at 5.0%; we forecast it to reach 3.9% by 2025. However, we remain Equal-weight on the shares as we see a more defensive deposit beta in NBG in the coming quarters.

Just got through the KW CC. Interesting to see they picked up so many of the Pacwest team. “For example, in June, we sourced and acquired off market a $4.1 billion construction loan portfolio from a regional bank at a discount, representing the largest single transaction in our company’s history. This transaction was possible given our reputation in the banking industry and our ability to move with speed and certainty to get a transaction of this size closed inside of 30 days.” “During Q3, we welcomed 40 new employees from the regional bank I mentioned, who have integrated perfectly into our existing operations and considerably strengthened our lending capabilities. We are currently one of the few active construction lenders in the U.S. market, and our team has a strong pipeline of new loans, of which a significant amount will close here in the fourth quarter.”

Certainly is interesting at these levels. Flies in the face of my resolution to never to invest in a FFH holding but I do have respect for Bill.

+1 Reposting the link to TRS below because it is important to understand this is a well considered directional bet that @StubbleJumper points out could unwind in a heart beat with a big market sell off, not to mention the cost to finance is now material. It's worked out great but the risk reward has now narrowed considerably. My expectation is they ditch this around 1.1-1.2x’s book, Prem’s $1000 per share. I won’t be disappointed to see this levered play disappear this financial year or early next year at the latest.. https://corporatefinanceinstitute.com/resources/derivatives/total-return-swap-trs/#

Why would they? Fairfax is renting their balance sheet. Fairfax is the one placing a directional bet not the counterparty. They are Fairfax “agnostic”.

MS put out a note on Japanese prospects (attached) which may be of interest to some here. They offer the following: “Sustained reflation and rising productivity at the macro level - working in combination with improved corporate governance at the micro level - will likely drive further improvement in corporate profitability in Japan. We raise our forecast for MSCI Japan Return on Equity to 12% (from 11%) by year-end 2025. This would be almost 2.5x the level when Abenomics was launched in late 2012. In turn, that will likely drive further valuation re-rating from 14x P/B to 1.8x and market outperformance versus global equity peers.” japan_20231017_2000.pdf

Some speculation on how the current Canadian/India frostiness may affect the sale process for IDBI bank https://www.thehindubusinessline.com/money-and-banking/idbi-bank-divestment-indo-canadian-spat-may-dim-fairfaxs-chance/article67427015.ece "Fairfax India Holdings, the investment arm of Indian-origin Canadian billionaire Prem Watsa, seen as one of the top contenders for IDBI Bank, could now be in the back seat — thanks to the ongoing geopolitical spat between India and Canada. Highly placed sources say with the political tension not easing anytime soon, Fairfax’s is unlikely to be at an advantageous position to secure IDBI Bank in the ongoing divestment process. “If the tension between the two countries escalates or doesn’t end soon, Fairfax may lose its edge in the process,” the source said." Also an update on the timing "Amidst talks of delay in the divestment of IDBI Bank, people close to the development say the process is very much intact and the sale may conclude before March 31, 2024. While the bidding timelines for appointment of asset valuers has been extended from October 9-10 to October 30-31, it is gathered that the delay is more due to change in clauses pertaining to the bidding process based on suggestions received from potential bidders." From what I can gather, the bid is being put forward via Fairfax India and CSB https://bfsi.economictimes.indiatimes.com/news/banking/idbi-bank-sale-rbi-set-to-complete-vetting-of-buyers-bids-likely-early-next-year/104452746 IDBI Current Market Cap INR750 Bn =>$US9.02bn Stake to be sold off 60.7% x $9bn >=> $5.5bn As stated previously, this would be a massive purchase, so I have been wondering, given Eurobank's aspirations for India, whether they might participate in a book build. It's probably too messy, but you never know. OMERS?

Thanks @SafetyinNumbers. What is RBC's price target? Taking these numbers or @Viking great work, this still seems very cheap. The current price surely is predicated on capital destruction at some point, either through misallocation of capital, seizure of foreign assets or massive policy misplacing. Running a 20 year test on P/B. The mean for Markel, Berkshire, Fairfax is: MKL 1.5x BRK 1.4x FFH. 1.0x Nothing new in the observation that long ROE is what will drive share price. Over the last 20 years Mean ROE has been MKL 7.9% BRK 9.3% FFH 8.1% I totally agree with the observation that for a decade of this period, the float was not adding meaningfully to ROE, that's changed. A couple of years of +1 STD deviation (18%) in FFH's ROE seems very likely. Whether this results in +1 standard deviation of 1.3x's book I am not sure, but it seems like an asymmetric bet.

Any chance you could post the RBC model?

Seems fully priced but interesting suggestion. Given the ever growing number of shitshows, defence contractors might be a sensible hedge. Any particular mispricing/insight? “Elbit Systems Ltd is a globally recognized defense electronics company based in Israel. It specializes in the design, development, manufacturing, and integration of advanced systems and equipment primarily for defense, homeland security, and aerospace sectors. Here’s a more detailed breakdown of the company’s profile: 1. Core Expertise: • Aerospace, Defense, and Homeland Security Solutions: Elbit Systems provides a broad range of solutions across airborne, land, and naval domains. This includes systems and equipment for command, control, communications, computers, intelligence, surveillance, and reconnaissance (C4ISR) among others . • Precision Weaponry and Surveillance Systems: The company has a notable emphasis on delivering advanced surveillance and precision weaponry systems, which form a part of its extensive portfolio . 2. Global Presence: • Elbit Systems operates internationally, engaging in a wide range of programs throughout the world. This global outreach allows it to cater to different markets and clientele, including various governmental agencies . 3. Historical Background: • Founded in 1976, Elbit Systems has built a legacy over the decades as a reliable provider of defense electronics and related services to the military and homeland security sectors . 4. Innovative Technology: • The company is known for its high-performance defense electronic and electro-optic systems. It continues to invest in innovative technology, aiming to deliver integrated and network-centric solutions . Elbit Systems’ diverse portfolio and its emphasis on innovation underline its commitment to meeting the evolving needs of its global clientele in the defense and security sectors.”

@Viking Great work as always. Agree capital allocation/deal flow is key moving forwards. Higher for longer definitely helps though, if nothing else it keeps the proverbial foot on the competition’s throat. Analysts forecasts are still very much in the “they screw it up” and interest rates fall fast. FWIW (not much) this is the view of the few: FY23 $US135, FY24 $US118 and FY25 $US79 they then fall of the proverbial cliff (our Morningstar friend no doubt). A very different view indeed. In terms of capital allocation, I see a minimum 10% just via Omer’s buybacks, then around 12-15% buying back their own shares. So they should have no problems reallocating incremental capital at sensible rates at least for the next few years. Even then, I don’t believe that the 11-12% compounding machine, that has been in operation for 30+ years, is broken. You have to keep telling yourself that if these “analysts” were any good they would be running their own book.

Definitely starting to look interesting . So much easier when yesterday’s hero’s flatline for 5 years but we are getting close.

FFH.TO

Trimmed AAPL, MKL

Roughly right as always

Maybe that old quote should be written along the lines of "The analyst can remain irrational longer than the market becomes a weighing machine."

I hope you are right. I had to chuckle at Morgan Stanley participating in the option review, and surprise, surprise, the answer was an IPO . FWIW MS are also involved with the much-delayed Digit IPO.

Blackberry splitting out IOT via an IPO https://finance.yahoo.com/news/blackberry-separate-iot-cybersecurity-business-212416261.html

Thoroughly agree, one of my favourites. I have watched it a couple of times. Interesting to see it’s now on Amazon, I think I came across it on free to air during covid and ended up buying it, to avoid ads. Dark, gritty, and reminds me of so many great movies/shows but still unique storytelling. Glad you are enjoying it.

So including divs FFH @ 1x’s book is a 12% CAGR. Interestingly this is close to my base case. Still plenty of room for P/B expansion and earnings growth. Extraordinary really. Thanks for the graph.

Thanks @Viking, the alpha is impressive. Always nice to see a position like OXY showing up that is in the "I wish I had done that, but it doesn't matter because Fairfax did".

Thanks, always good to see another example of a rational capital allocation coming to light

Nah, should have had my morning coffee before posting There has been some rumours doing the rounds about the ECB raising the minimum reserve requirements (MRR). Morgan Stanley did some modelling attached, TLDR minimal impact on Eurobank. I guess I am just a little surprised as I figured this would be up and to the right given the low valuation but Greece has been suffering their share of misfortunes of late. eemea_20230919_0946.pdf

Why buy for $1 when you can pay $1.20. I am not not surprised the share price went down considerably. Still under book (€1.99) so will be accretive but I am speculating that it buys some political good will down the track. I was really hoping they would get this done around market value of say €1.50-1.60 rather than €1.80 https://www.ekathimerini.com/economy/1220864/hfsf-launches-disposal-of-its-stake-in-eurobank/